PACTR202202797930675已完成2 期
Safety and Efficacy of Calcium Montmorillonite Clay (Novasil) in Children at Risk of Aflatoxin related Diseases in Ejura Sekyedumase District, Ghana (PhaseII)
未提供0 个研究点目标入组 200 人开始时间: 2022年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •1Healthy (upon physical examination by a physician)
- •2No chronic illness
- •3No use of medications for acute illnesses or chronic illness
- •4Aflatoxin M1 (AFM1) > 0.5ug/kg)
- •5Normal hemoglobin level (greater than 10.5g/dL)
排除标准
- •1Abnormal hemoglobin level (below 10.5g/dl)
- •2Chronic illness
- •3Use of medications for chronic or acute illness.
- •4 Aflatoxin M1 (AFM1) <0.5ug/kg)
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center
尚未招募
3 期
Efficacy and Safety of Chelation Therapy with Calcium Disodium EDTA (ethylenediaminetetraacetic acid) in the Progression of Chronic Kidney Disease of Unknown Etiology in Sri LankaChronic Kidney Disease of Unknown EtiologySLCTR/2018/021niversity of Colombo
尚未招募
2 期
comparative evaluation of three different root canal medicaments in reducing paiCTRI/2024/08/071970Dr Itika Jain
尚未招募
不适用
use of different bone grafts in the treatment of chronic periodontitisCTRI/2020/04/024785JUWERIA WAJID
招募中
2 期
Efficacy of Cinacalcet in the Treatment of Secondary HyperparathyroidismIRCT20200218046533N1Gorgan University of Medical Sciences70